Cuota de mercado, dinámica y crecimiento de los análisis de drogas en 2022</font></font>

Name: Mercado de detección de drogas por producto (consumibles, dispositivos de análisis de orina, analíticos, alcoholímetros, cromatografía, inmunoensayos) y servicios, tipo de muestra (orina, aliento, fluido oral/saliva, cabello y otras muestras (sangre y sudor)), usuario final (lugar de trabajo, laboratorios, justicia penal, hospitales) y región (América del Norte, Europa, Asia-Pacífico, Oriente Medio y África, y América del Sur), tendencias globales y pronóstico de 2022 a 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (97 reviews)
Author: Exactitude Consultancy
ISBN: 8956

Descripción general del mercado de detección de drogas

Se espera que el mercado mundial de detección de drogas crezca a una tasa anual compuesta del 17 % entre 2022 y 2029. Se espera que alcance más de 6070 millones de dólares en 2029 desde 5210 millones de dólares en 2020.

El análisis de drogas es un método para detectar drogas ilegales y de venta con receta en la sangre, la orina y otros fluidos corporales. También se utiliza para determinar la cantidad de droga que se está consumiendo y es un aspecto importante de la evaluación y el tratamiento continuos. En el caso de los atletas universitarios y profesionales, así como en el caso de las pruebas de drogas posteriores a accidentes, se realizan en escuelas, hospitales y lugares de trabajo. Las pruebas aleatorias, las pruebas de reincorporación al trabajo, las pruebas previas al empleo, las pruebas de sospecha o causa razonable y las pruebas de seguimiento son ejemplos de esto.

Al postularse a empleos en los sectores ferroviario, de aviación, de transporte federal y otras áreas donde la seguridad pública es una prioridad, se exigen pruebas de detección de drogas. Además, en el nivel universitario y en el caso de los atletas profesionales, las pruebas de detección de drogas deportivas son necesarias para detectar drogas ilegales, recreativas o para mejorar el rendimiento, como la hormona de crecimiento humana recombinante, los diuréticos, la ergoprogesterona, los esteroides anabólicos y otros. La heroína, el cannabis , la cocaína, el éxtasis y la anfetamina son algunas de las drogas ilícitas de uso más frecuente.

ATRIBUTO	DETALLES
Periodo de estudio	2020-2029
Año base	2021
Año estimado	2022
Año pronosticado	2022-2029
Periodo histórico	2018-2020
Unidad	Valor (miles de millones de USD)
Segmentación	Por producto y servicios, por tipo de muestra, por usuario final
Por productos y servicios	Consumibles Dispositivos para análisis de orina Analítico Alcoholimetro Cromatografía Inmunoensayo
Por tipo de muestra	Orina Aliento Fluido oral/saliva Cabello Otras muestras (sangre y sudor)
Por el usuario final	Lugar de trabajo Laboratorios Justicia penal Hospitales
Por región	América del norte Europa Asia Pacífico Sudamerica Oriente Medio y África

Las nuevas sustancias psicoactivas (NSP), como las fenetilaminas, la ketamina, la piperazina y las triptaminas, también están ganando popularidad en la industria farmacéutica. Debido a su bajo costo y alta confiabilidad, la orina es la muestra más utilizada para las pruebas. Las pruebas iniciales y confirmatorias de detección de drogas son parte de un proceso de dos pasos.

El brote de COVID-19 ha tenido una influencia significativa en el negocio de detección de drogas. Para combatir el brote de la pandemia de COVID-19, el gobierno impuso restricciones de confinamiento y distanciamiento social en viajes, reuniones públicas, operaciones comerciales y órdenes de quedarse en casa, lo que resultó en una disponibilidad limitada o nula de instalaciones médicas/centros de tratamiento, así como en la paralización de varias operaciones, una demanda reducida e interrupciones en la cadena de suministro, lo que limitó la expansión de la industria. El crecimiento del mercado de detección de drogas se vio obstaculizado aún más por el aplazamiento de servicios médicos no esenciales debido a la pandemia de COVID-19. El desequilibrio entre la oferta y la demanda se ha ampliado como resultado de los obstáculos comerciales.

El gran grupo de pacientes, el creciente número de drogadictos, el desarrollo de dispositivos avanzados de detección de drogas y alcohol, la creciente conciencia de la importancia de la detección de drogas y alcohol y el aumento de los niveles de ingresos disponibles en los países son las principales fuerzas impulsoras del mercado de detección de drogas en los países en desarrollo. El creciente abuso de drogas y alcohol, el aumento de la población geriátrica, el alto consumo de alcohol y drogas recetadas e ilegales, la aprobación de leyes estrictas que obligan a realizar pruebas de abuso de drogas y alcohol en los países desarrollados, el aumento de la financiación y las iniciativas gubernamentales para las pruebas de drogas, la creciente conciencia sobre la detección de drogas en los países desarrollados y el aumento de la población mundial son algunos de los factores clave que impulsan el crecimiento del mercado mundial de detección de drogas.

Algunos países, como Canadá, Colombia, Argentina, Chile y Sudáfrica, consideran que las pruebas de drogas en algún lugar (en particular el lugar de trabajo) constituyen una violación a la privacidad de los empleados, lo que se espera que restrinja el crecimiento del mercado.

Muchos países tienen leyes estrictas que prohíben el uso o consumo de drogas. Se espera que la implementación de normas estrictas para los análisis de drogas abra oportunidades lucrativas para el sector. Además, el uso cada vez mayor de los análisis de drogas basados en huellas dactilares ha ganado una enorme popularidad en los últimos años y se espera que ofrezca una variedad de oportunidades de crecimiento.

El mayor desafío en el mercado de detección de drogas es la prohibición del consumo de drogas en ciertos lugares y los problemas de precisión relacionados con los alcoholímetros.

[título id="attachment_8973" align="aligncenter" width="870"]

Drug Screening Market | Exactitude Consultancy

Mercado de detección de drogas | Exactitude Consultancy[/subtítulo]

Frequently Asked Questions

• What is the worth of global drug screening market?

The drug screening market size had crossed 5.21 billion in 2020 and will observe a CAGR of more than 6% up to 2029 and is driven by the large group of patients, growing number of drug addicts, development of advanced drug and alcohol screening devices.

• What is the size of the North America drug screening industry?

North America held 49% of the drug screening market revenue share in 2020 and is driven by the rising consumption of illicit drugs, the availability of government funding to combat drug abuse, laws supporting drug screening etc.

• What are the upcoming trends of drug screening market, globally?

The upcoming trends in drug screening market is growing drug and alcohol consumption

• What is the CAGR of drug screening market?

The global drug screening market registered a CAGR of 17 % from 2022 to 2029. The consumables segment was the highest revenue contributor to the market.

• Which are the top companies to hold the market share in drug screening market?

Key players profiled in the report include LabCorp, Quest Diagnostics, Abbott Laboratories, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, MPD Inc., Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, and Siemens Healthineers.

• What is the leading application of drug screening market?

It is used to figure out how much of a drug you're using.

• Which is the largest regional market for drug screening market?

North America is the largest regional market for drug screening market.

Drug Screening Market Segment Analysis

On the basis of product, the market is segmented into Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay. On the basis of sample type, the market is bifurcated into Urine, Breath, Oral Fluid/Saliva, Hair, and Other Samples (Blood and Sweat). Based on end-user, the drug screening market is segmented into Workplace, Laboratories, Criminal Justice, Hospitals.

The consumables segment dominated the market. The market's growth has been boosted by the increased introduction of new consumables that provide better options for making testing easy, accurate, and quick.

The urine samples segment led the market, accounting for the majority of the revenue. During the forecast period, the segment is expected to increase at the fastest rate. Urine samples are the most often utilized sample type to detect the presence of illicit substances, which explains the rapid rise. However, adulteration of urine samples is becoming increasingly widespread, resulting in false-negative test results, which can have a negative impact on market growth.

In 2021, drug testing laboratories dominated the market. This high percentage can be attributed to their widespread acceptance as a result of their accuracy. Rapid tests cannot detect the presence of any illicit substance, whereas drug-testing laboratories can. The availability of advanced technology, such as HPLC and spectroscopy, and skilled employees for conducting tests for effective findings are also advantages of drug testing facilities. As a result, laboratory testing results have higher sensitivity and specificity than quick tests.

[caption id="attachment_8972" align="alignleft" width="680"]

Drug Screening Market | Exactitude Consultancy[/caption]

Drug Screening Market Players

The prominent players operating in this market include LabCorp, Quest Diagnostics, Abbott Laboratories, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, MPD Inc., Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, and Siemens Healthineers.

These companies have adopted various organic as well as inorganic growth strategies to strengthen their position in the market. New product development, merger & acquisition, and expansion were among the key growth strategies adopted by these leading players to enhance their product offering and regional presence and meet the growing demand for drug screening in the emerging economies.

In 2021, Quest Diagnostics and Select Health of South Carolina announced a partnership to extend Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees, as well as to improve members' access to diagnostics information services.
In 2020, LabCorp signed a multi-year arrangement with Infirmary Health to provide laboratory testing services in the eastern Gulf Coast.
In 2020, Psychemedics released a vaping panel test that identifies marijuana, CBD, and nicotine medication intake via all means, including electronic cigarettes or smoking.

Who Should Buy? Or Key Stakeholders

Drug screening suppliers
Investors
Manufacturing companies
End-user companies
Research institutes
Healthcare
Environment, Health and Safety Professionals
Others

Drug Screening Market Regional Analysis

The global drug screening market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

With a 49% share of the global market in 2021, North America is the largest regional sector, followed by Europe. Factors such as the rising consumption of illicit drugs, the availability of government funding to combat drug abuse, laws supporting drug screening, the rising number of accidents caused by alcohol impairment, and the presence of key players in the region are all driving the growth of the drug screening market in this region. [caption id="attachment_8975" align="alignleft" width="680"]

Drug Screening Market | Exactitude Consultancy[/caption]

Key Market Segments: Global Drug Screening Market

Global Drug Screening Market by Product and Services, 2020-2029, (USD Million)

Consumables
Urine Testing Devices
Analytical
Breathalyzer
Chromatography
Immunoassay

Global Drug Screening Market by Sample Type, 2020-2029, (USD Million)

Urine, Breath
Oral Fluid/Saliva
Hair
Other Samples (Blood & Sweat)

Global Drug Screening Market by End User Industry, 2020-2029, (USD Million)

Workplace
Laboratories
Criminal Justice
Hospitals

Global Drug Screening Market by Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important countries in all regions are covered.

Key Question Answered

What are the growth opportunities related to the adoption of drug screening market across major regions in the future?
What are the new trends and advancements in the drug screening market?

Which product categories are expected to have highest growth rate in the drug screening market?

Which are the key factors driving the drug screening market?
What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

Introducción
1. Definición de mercado
2. Segmentación del mercado
3. Cronología de la investigación
4. Supuestos y limitaciones

Metodología de la investigación
1. Minería de datos
  1. Investigación secundaria
  2. Investigación primaria
  3. Asesoramiento de expertos en la materia
2. Controles de calidad
  1. Revisión final
3. Triangulación de datos
  1. Enfoque de abajo hacia arriba
  2. Enfoque de arriba hacia abajo
  3. Flujo de investigación
4. Fuentes de datos

Resumen ejecutivo

Descripción general del mercado
1. Perspectivas del mercado mundial de detección de drogas
  1. Factores impulsores del mercado
  2. Restricciones del mercado
  3. Oportunidades de mercado
2. Impacto de la COVID-19 en el mercado mundial de detección de drogas

Mercado mundial de detección de drogas por producto y servicios (millones de USD)
1. Consumibles
2. Dispositivos para análisis de orina
3. Analítico
4. Alcoholimetro
5. Cromatografía
6. Inmunoensayo

Global Drug Screening Market by Sample Type, (USD Million)
1. Urine
2. Breath
3. Oral Fluid/Saliva
4. Hair
5. Other Samples (Blood & Sweat)

Global Drug Screening Market by End-User Industry, (USD Million)
1. Workplace
2. Laboratories
3. Criminal Justice
4. Hospitals

Global Drug Screening Market by Region, (USD Million)
1. Introduction
2. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest of Asia-Pacific
3. North America
  1. United States
  2. Canada
  3. Mexico
4. Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
5. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest of South America
6. Middle- East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest of Middle- East and Africa

Company Profiles* (Business Overview, Company Snapshot, Product Types Offered, Recent Developments)

1. LabCorp
2. Quest Diagnostics
3. Abbott Laboratories
4. OraSure Technologies
5. Alfa Scientific Designs
6. Thermo Fisher Scientific
7. Drägerwerk
8. LifeLoc
9. MPD Inc.
10. Omega Laboratories
11. Premier Biotech
12. Psychemedics
13. Roche
14. Shimadzu
15. Siemens Healthineers

*The Company List Is Indicative

LIST OF TABLES

TABLE 1                GLOBAL DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 2                GLOBAL DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 3                GLOBAL DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 4                GLOBAL DRUG SCREENING MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 5                NORTH AMERICA DRUG SCREENING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 6                NORTH AMERICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 7                NORTH AMERICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 8                NORTH AMERICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 9                US DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 10              US DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 11              US DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 12              CANADA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (MILLIONS), 2020-2029

TABLE 13              CANADA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 14              CANADA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 15              MEXICO DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 16              MEXICO DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 17              MEXICO DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 18              SOUTH AMERICA DRUG SCREENING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 19              SOUTH AMERICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 20              SOUTH AMERICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 21              SOUTH AMERICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 22              BRAZIL DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 23              BRAZIL DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 24              BRAZIL DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 25              ARGENTINA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 26              ARGENTINA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 27              ARGENTINA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 28              COLOMBIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 29              COLOMBIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 30              COLOMBIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 31              REST OF SOUTH AMERICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 32              REST OF SOUTH AMERICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 33              REST OF SOUTH AMERICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 34              ASIA-PACIFIC DRUG SCREENING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 35              ASIA-PACIFIC DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 36              ASIA-PACIFIC DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 37              ASIA-PACIFIC DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 38              INDIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 39              INDIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 40              INDIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 41              CHINA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 42              CHINA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 43              CHINA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 44              JAPAN DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 45              JAPAN DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 46              JAPAN DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 47              SOUTH KOREA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 48              SOUTH KOREA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 49              SOUTH KOREA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 50              AUSTRALIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 51              AUSTRALIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 52              AUSTRALIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 53              SOUTH EAST ASIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 54              SOUTH EAST ASIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 55              SOUTH EAST ASIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 56              REST OF ASIA PACIFIC DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 57              REST OF ASIA PACIFIC DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 58              REST OF ASIA PACIFIC DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 59              EUROPE DRUG SCREENING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 60              EUROPE DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 61              EUROPE DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 62              EUROPE DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 63              GERMANY DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 64              GERMANY DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 65              GERMANY DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 66              UK DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 67              UK DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 68              UK DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 69              FRANCE DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 70              FRANCE DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 71              FRANCE DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 72              ITALY DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 73              ITALY DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 74              ITALY DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 75              SPAIN DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 76              SPAIN DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 77              SPAIN DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 78              RUSSIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 79              RUSSIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 80              RUSSIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 81              REST OF EUROPE DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 82              REST OF EUROPE DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 83              REST OF EUROPE DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 84              MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 85              MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 86              MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 87              MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 88              UAE DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 89              UAE DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 90              UAE DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 91              SAUDI ARABIA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 92              SAUDI ARABIA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 93              SAUDI ARABIA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 94              SOUTH AFRICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 95              SOUTH AFRICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 96              SOUTH AFRICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 97              REST OF MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY PRODUCTS & SERVICES (USD MILLIONS), 2020-2029

TABLE 98              REST OF MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY SAMPLE TYPE (USD MILLIONS), 2020-2029

TABLE 99              REST OF MIDDLE EAST AND AFRICA DRUG SCREENING MARKET BY END USER (USD MILLIONS), 2020-2029

LIST OF FIGURES

FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL DRUG SCREENING MARKET BY PRODUCT AND SERVICES, USD MILLION, 2020-2029

FIGURE 9             GLOBAL DRUG SCREENING MARKET BY SAMPLE TYPE, USD MILLION, 2020-2029

FIGURE 10           GLOBAL DRUG SCREENING MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 11           GLOBAL DRUG SCREENING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           GLOBAL DRUG SCREENING MARKET BY PRODUCT AND SERVICES, USD MILLION, 2020-2029

FIGURE 14           GLOBAL DRUG SCREENING MARKET BY SAMPLE TYPE, USD MILLION, 2020-2029

FIGURE 15           GLOBAL DRUG SCREENING MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 16           GLOBAL DRUG SCREENING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 17           DRUG SCREENING MARKET BY REGION 2021

FIGURE 18           MARKET SHARE ANALYSIS

FIGURE 19           LABCORP: COMPANY SNAPSHOT

FIGURE 20           QUEST DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 21           ABBOTT LABORATORIES: COMPANY SNAPSHOT

FIGURE 22           ORASURE TECHNOLOGIES: COMPANY SNAPSHOT

FIGURE 23           ALFA SCIENTIFIC DESIGNS: COMPANY SNAPSHOT

FIGURE 24           THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 25           DRÄGERWERK: COMPANY SNAPSHOT

FIGURE 26           LIFELOC: COMPANY SNAPSHOT

FIGURE 27           MPD INC.: COMPANY SNAPSHOT

FIGURE 28           OMEGA LABORATORIES: COMPANY SNAPSHOT

FIGURE 29           PREMIER BIOTECH: COMPANY SNAPSHOT

FIGURE 30           PSYCHEMEDICS: COMPANY SNAPSHOT

FIGURE 31           ROCHE: COMPANY SNAPSHOT

FIGURE 32           SHIMADZU: COMPANY SNAPSHOT

FIGURE 33           SIEMENS HEALTHINEERS: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Drug Screening Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Descripción general del mercado de detección de drogas

Frequently Asked Questions

• What is the worth of global drug screening market?

• What is the size of the North America drug screening industry?

• What are the upcoming trends of drug screening market, globally?

• What is the CAGR of drug screening market?

• Which are the top companies to hold the market share in drug screening market?

• What is the leading application of drug screening market?

• Which is the largest regional market for drug screening market?

Drug Screening Market Segment Analysis

Drug Screening Market Players

Who Should Buy? Or Key Stakeholders

Drug Screening Market Regional Analysis

Key Market Segments: Global Drug Screening Market

Key Question Answered

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept